An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

Compounded semaglutide, which contains the same active ingredient as Ozempic and Wegovy, is available from ... until the expiration date shown on the vial. But after it’s opened, compounded ...

Both companies have been struggling to meet massive demand for their products – Zepbound and Wegovy are both on the FDA's list of medicines in short supply – and a simpler-to-produce vial ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

In obesity, it will compete with Novo Nordisk’s GLP-1 agonist Wegovy (semaglutide), which ... but has initially been made available in vials only as Lilly waits for EU approval of the KwikPen ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper into these ...